YBX1 and cutaneous mastocytosis: We performed a prognostic risk score signature containing DNMT2, NSUN3, NSUN6, YBX1, and NOP2 using a LASSO Cox regression model according to the minimum criterion to evaluate the prognosis value of m5C methylation modification on individual CM patients accurately (Figure 4(a)).